<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ma Y</submitter><funding>NCATS NIH HHS</funding><funding>NIA NIH HHS</funding><funding>NIDA NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute on Aging</funding><funding>NIMHD NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute on Minority Health and Health Disparities</funding><funding>NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | National Institutes of Health</funding><pagination>2074-2083</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10901568</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(12)</volume><pubmed_abstract>Average ambient fine particulate matter (PM&lt;sub>2.5&lt;/sub>) concentrations have decreased in the US in recent years, but the health benefits of this improvement among different racial/ethnic groups are unknown. We estimate the associations between long-term exposure to ambient PM&lt;sub>2.5&lt;/sub> and cause-specific cardiovascular disease (CVD) mortality rate and assess the PM&lt;sub>2.5&lt;/sub>-attributable CVD deaths by race/ethnicity across 3,103 US counties during 2001-2016 (n = 595,776 county-months). A 1 µg m&lt;sup>-&lt;/sup>&lt;sup>3&lt;/sup> increase in PM&lt;sub>2.5&lt;/sub> concentration was associated with increases of 7.16 (95% confidence interval (CI): 3.81, 10.51) CVD deaths per 1,000,000 Black people per month, significantly higher than the estimates for non-Hispanic white people (1.76 (95% CI: 1.37, 2.15); difference in coefficients: 5.40 (95% CI: 2.03, 8.77), P = 0.001). No significant difference in this association was observed between Hispanic (2.66 (95% CI: -0.03, 5.35)) and non-Hispanic white people (difference in coefficients: 0.90 (95% CI: -1.81, 3.61), P = 0.523). From 2001 to 2016, the absolute disparity in PM&lt;sub>2.5&lt;/sub>-attributable CVD mortality burden was reduced by 44.04% between non-Hispanic Black and white people and by 2.61% between Hispanic and non-Hispanic white people. However, in 2016, the burden remained 3.47 times higher for non-Hispanic Black people and 0.45 times higher for Hispanic people than for non-Hispanic white people. We call for policies that aim to reduce both exposure and vulnerability to PM&lt;sub>2.5&lt;/sub> for racial/ethnic minorities.</pubmed_abstract><journal>Nature human behaviour</journal><pubmed_title>Racial/ethnic disparities in PM&amp;lt;sub&amp;gt;2.5&amp;lt;/sub&amp;gt;-attributable cardiovascular mortality burden in the United States.</pubmed_title><pmcid>PMC10901568</pmcid><funding_grant_id>P30AG021342</funding_grant_id><funding_grant_id>R21 AG074238</funding_grant_id><funding_grant_id>R01MD016054</funding_grant_id><funding_grant_id>R01 MD017298</funding_grant_id><funding_grant_id>R01 MD016054</funding_grant_id><funding_grant_id>DP5OD029636</funding_grant_id><funding_grant_id>P30 AG021342</funding_grant_id><funding_grant_id>L60 DA054692</funding_grant_id><funding_grant_id>R21AG074238-01</funding_grant_id><funding_grant_id>UL1 TR001863</funding_grant_id><funding_grant_id>DP5 OD029636</funding_grant_id><funding_grant_id>DP1 DA058982</funding_grant_id><pubmed_authors>Chen K</pubmed_authors><pubmed_authors>Lu Y</pubmed_authors><pubmed_authors>Krumholz HM</pubmed_authors><pubmed_authors>Ma Y</pubmed_authors><pubmed_authors>Zang E</pubmed_authors><pubmed_authors>Opara I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Racial/ethnic disparities in PM&amp;lt;sub&amp;gt;2.5&amp;lt;/sub&amp;gt;-attributable cardiovascular mortality burden in the United States.</name><description>Average ambient fine particulate matter (PM&lt;sub>2.5&lt;/sub>) concentrations have decreased in the US in recent years, but the health benefits of this improvement among different racial/ethnic groups are unknown. We estimate the associations between long-term exposure to ambient PM&lt;sub>2.5&lt;/sub> and cause-specific cardiovascular disease (CVD) mortality rate and assess the PM&lt;sub>2.5&lt;/sub>-attributable CVD deaths by race/ethnicity across 3,103 US counties during 2001-2016 (n = 595,776 county-months). A 1 µg m&lt;sup>-&lt;/sup>&lt;sup>3&lt;/sup> increase in PM&lt;sub>2.5&lt;/sub> concentration was associated with increases of 7.16 (95% confidence interval (CI): 3.81, 10.51) CVD deaths per 1,000,000 Black people per month, significantly higher than the estimates for non-Hispanic white people (1.76 (95% CI: 1.37, 2.15); difference in coefficients: 5.40 (95% CI: 2.03, 8.77), P = 0.001). No significant difference in this association was observed between Hispanic (2.66 (95% CI: -0.03, 5.35)) and non-Hispanic white people (difference in coefficients: 0.90 (95% CI: -1.81, 3.61), P = 0.523). From 2001 to 2016, the absolute disparity in PM&lt;sub>2.5&lt;/sub>-attributable CVD mortality burden was reduced by 44.04% between non-Hispanic Black and white people and by 2.61% between Hispanic and non-Hispanic white people. However, in 2016, the burden remained 3.47 times higher for non-Hispanic Black people and 0.45 times higher for Hispanic people than for non-Hispanic white people. We call for policies that aim to reduce both exposure and vulnerability to PM&lt;sub>2.5&lt;/sub> for racial/ethnic minorities.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Dec</publication><modification>2025-04-19T16:11:36.583Z</modification><creation>2025-04-19T16:11:36.583Z</creation></dates><accession>S-EPMC10901568</accession><cross_references><pubmed>37653149</pubmed><doi>10.1038/s41562-023-01694-7</doi></cross_references></HashMap>